Psychometric validation of the functional assessment of cancer therapy-brain (FACT-Br) for assessing quality of life in patients with brain metastases

Supportive Care in Cancer

Volumn 22, Issue 4, 2014, Pages 1017-1028

  Thavarajah, Nemica ^a   Bedard, Gillian ^a   Zhang, Liying ^a   Cella, David ^b   Beaumont, Jennifer L ^b   Tsao, May ^a   Barnes, Elizabeth ^a   Danjoux, Cyril ^a   Sahgal, Arjun ^a   Soliman, Hany ^a   Chow, Edward ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b NORTHWESTERN UNIVERSITY   (United States)

^c DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Brain metastases; FACT Br; FACT G; Field testing; Psychometric validation; Quality of life; Questionnaire

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BRAIN CANCER SUBSCALE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; EMOTIONAL WELL BEING; FAMILY WELL BEING; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; FUNCTIONAL ASSESSMENT OF CANCER THERAPY BRAIN SUBSCALE; FUNCTIONAL WELL BEING; HUMAN; KARNOFSKY PERFORMANCE STATUS; MALE; MULTIMODALITY CANCER THERAPY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT HISTORY OF CHEMOTHERAPY; PHYSICAL WELL BEING; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; SOCIAL WELL BEING; STEREOTACTIC RADIOSURGERY; VERY ELDERLY; WELLBEING;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE;

EID: 84895891848     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-2060-8     Document Type: Article

References (20)

1. Doyle M, Bradley NM, Li K, Sinclair E, Lam K, Chan G et al (2007) Quality of life in patients with brain metastases treated with a palliative course of whole-brain radiotherapy. J Palliat Med 10(2):367-374 (Pubitemid 46740210)
2. Thomas SS, Dunbar EM (2010) Modern multidisciplinary management of brain metastases. Curr Oncol Rep 12(1):34-40
3. Eichler AF, Loeffler JS (2007) Multidisciplinary management of brain metastases. Oncologist 12(7):884-898 (Pubitemid 47328231)
4. Chang EL, Wefel JS, Maor MH, Hassenbusch SJ III, Mahajan A, Lang FF et al (2007) A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone. Neurosurgery 60(2):277-283, discussion 283-4
5. Posner JB (1977) Management of central nervous system metastases. Semin Oncol 4(1):81-91
6. Tsao MN, Lloyd N, Wong R, Chow E, Rakovitch E, Laperriere N (2006) Whole brain radiotherapy for the treatment of multiple brain metastases. Cochrane Database Syst Rev 3:003869
7. Movsas B (2003) Quality of life in oncology trials: a clinical guide. Semin Radiat Oncol 13(3):235-247
8. Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Cella DF, Levin VA (1995) The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 75(5):1151-1161
9. Chen E, Cella D, Zeng L, Thavarajah N, Zhang L, Chang E, et al. Content validation of the FACT-Br with patients and health-care professionals to assess quality of life in patients with brain metastases. Journal of Radiation Oncology 2012
10. Caissie A, Nguyen J, Chen E, Zhang L, Sahgal A, Clemons M et al (2012) Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL. Int J Radiat Oncol Biol Phys 83(4):1238-1245
11. Cicchetti DV, Sparrow SA (1981) Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behavior. Am J Ment Defic 86(2):127-137 (Pubitemid 11006962)
12. Nunnally JC, Bernstein IH (1994) Psychometric theory, 3rd edn. Mc Graw-Hill, New York
13. Cohen J (1988) Statistical power analysis for the behavioral science. Lawrence Erlbaum Associates, New Jersey
14. Lien K, Zeng L, Nguyen J, Cramarossa G, Cella D, Chang E et al (2011) FACT-Br for assessment of quality of life in patients receiving treatment for brain metastases: a literature review. Expert Rev Pharmacoecon Outcome Res 11(6):701-708
15. Li J, Bentzen SM, Li J, Renschler M, Mehta MP (2008) Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis. Int J Radiat Oncol Biol Phys 71(1):64-70 (Pubitemid 351506468)
16. Bezjak A, Adam J, Barton R, Panzarella T, Laperriere N, Wong CS et al (2002) Symptomresponse after palliative radiotherapy for patients with brain metastases. Eur J Cancer 38(4):487-496 (Pubitemid 34185387)
17. Wong J, Hird A, Zhang L, Tsao M, Sinclair E, Barnes E et al (2009) Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy. Int J Radiat Oncol Biol Phys 75(4): 1125-1131
18. Friendlander AH, Ettinger RL (2009) Karnofsky performance status scale. Spec Care Dent 29(4):147-148
19. Hempen C, Weiss E, Hess CF (2002) Dexamethasone treatment in patients with brain metastases and primary brain tumors: do the benefits outweigh the side-effects? Support Care Cancer 10(4):322-328 (Pubitemid 36056287)
20. Tsao M, Xu W, Sahgal A (2012) A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases. Cancer 118(9):2486-2493